LBRX short interest
LB Pharmaceuticals Inc Common Stock · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,010,646 |
|---|---|
| Change vs prior report | 393,464 (+7.0%) |
| Change over six months | +129.3% |
| Days to cover | 14.51 (sector: 3.78) |
| Average daily volume | 414,301 |
| Rank in Healthcare | #39 of 922 by days to cover |
LBRX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,010,646 | +7.0% | 14.51 | 414,301 |
| 2026-09-15 | 5,617,182 | +6.4% | 21.45 | 261,863 |
| 2026-08-31 | 5,278,529 | +2.4% | 19.89 | 265,345 |
| 2026-08-14 | 5,156,413 | +8.6% | 12.38 | 416,373 |
| 2026-07-31 | 4,746,857 | +11.4% | 12.80 | 370,847 |
| 2026-07-15 | 4,260,793 | -6.4% | 17.59 | 242,211 |
| 2026-06-30 | 4,550,288 | +5.8% | 9.78 | 465,331 |
| 2026-06-15 | 4,302,626 | +7.2% | 24.75 | 173,854 |
| 2026-05-29 | 4,015,182 | -0.1% | 21.81 | 184,107 |
| 2026-05-15 | 4,018,158 | +5.8% | 31.18 | 128,873 |
| 2026-04-30 | 3,799,720 | +22.2% | 14.77 | 257,232 |
| 2026-04-15 | 3,110,447 | +18.6% | 8.80 | 353,456 |
| 2026-03-31 | 2,621,739 | -3.4% | 9.53 | 275,131 |
| 2026-03-13 | 2,713,021 | +3.7% | 12.48 | 217,473 |
| 2026-02-27 | 2,615,602 | +18.9% | 12.27 | 213,128 |
| 2026-02-13 | 2,199,776 | +21.9% | 12.35 | 178,137 |
| 2026-01-30 | 1,804,088 | +0.8% | 10.12 | 178,270 |
| 2026-01-15 | 1,790,725 | -2.4% | 6.94 | 258,049 |
| 2025-12-31 | 1,833,981 | +294.8% | 2.70 | 678,833 |
| 2025-12-15 | 464,576 | +91.5% | 1.71 | 272,216 |
| 2025-11-28 | 242,536 | -2.9% | 1.75 | 138,444 |
| 2025-11-14 | 249,832 | +12.0% | 2.29 | 109,087 |
| 2025-10-31 | 223,012 | -19.3% | 2.86 | 77,882 |
| 2025-10-15 | 276,214 | +39.1% | 1.16 | 238,770 |
| 2025-09-30 | 198,541 | +56.9% | 1.34 | 147,729 |
import finzdata as yf
yf.Ticker("LBRX").short_interest # every report since 2017
yf.Client().short_interest(["LBRX"], start="2018-01-01")Healthcare short interest · LBRX price history · Who owns LBRX · All short interest